Jennison Associates’s AnaptysBio ANAB Stock Holding History

Jennison Associates’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-269,131	Closed	-$3.56M	–	573
2024 Q4	$3.56M	Buy	269,131 +4,242	+2%	+$103K	﹤0.01%	430
2024 Q3	$8.87M	Buy	+264,889	New	+$9.05M	0.01%	395
2023 Q1	–	Sell	-19,802	Closed	-$614K	–	588
2022 Q4	$614K	Buy	+19,802	New	+$559K	﹤0.01%	550
2019 Q3	–	Sell	-162,422	Closed	-$9.16M	–	640
2019 Q2	$9.16M	Buy	162,422 +66,031	+69%	+$4.75M	0.01%	438
2019 Q1	$7.04M	Sell	96,391 -9	-0%	-$621	0.01%	453
2018 Q4	$6.15M	Sell	96,400 -2,193	-2%	-$163K	0.01%	472
2018 Q3	$9.84M	Buy	+98,593	New	+$8.18M	0.01%	471

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jennison Associates's ANAB Position: Q1 2025 in Review

Jennison Associates sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 269,131 shares — an estimated $3.56M sold.

Jennison Associates first reported a position in ANAB in Q3 2018 and held it in 7 quarters. The position peaked at $9.84M in Q3 2018. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

Jennison Associates reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
Jennison Associates sold 269,131 AnaptysBio shares in Q1 2025, an estimated $3.56M.
Jennison Associates first reported a position in AnaptysBio in Q3 2018 and held it in 7 quarters.
Jennison Associates's AnaptysBio position peaked at $9.84M in Q3 2018.
153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on Jennison Associates's 13F filing for Q1 2025, filed 5 May 2025.